Journal: Materials Today Bio
Article Title: Harnessing the dual immunomodulatory function of myeloid-derived suppressor cells to reshape the inflammatory microenvironment for osteoarthritis therapy
doi: 10.1016/j.mtbio.2025.102332
Figure Lengend Snippet: MDSCs exacerbate arthritis by promoting Th17 differentiation, but depleting MDSCs can alleviate the progression of osteoarthritis. (A) One week after the injection of MDSC, compared to the control group, the intra-articular levels of TNF-α, IFN-γ, IL-1β, and IL-6. (B) Flow cytometry showed the expression of IL-17A in the joints one week after the DMM surgery. One week after the injection of MDSC, compared to the control group, the intra-articular concentrations of IL-17 (C) in serum (D) in joint. (E) Immunofluorescence staining of CD4 and IL-17 in the joints and synovial membrane of mice one week after DMM surgery. (F) Immunofluorescence of COL2A1 and MMP-13 in ATDC5 cells co-cultured with Th17 cells for four days. (G) Quantitative analysis of immunofluorescence for COL2A1 and MMP-13. (H) Flow cytometry analysis of IL-17 expression and IL-17 levels in the culture supernatant after co-culturing MDSCs with CD4 + T cells for four days, compared to the control group. Mice were randomly sorted into 3 groups (Sham, Control, Anti-Gr-1, n = 6). The Anti-Gr-1 group received i.p. injected anti-Gr-1 antibodies (100 μg) twice a week, and animals were sacrificed four weeks after surgery. (I) Micro-CT images of knee joint after injection of anti-Gr-1 at 4 weeks. (J) Quantitative results of bone mineral density after injection of anti-Gr-1. (K) Safranin O-fast green, H&E staining of knee joints after injection of anti-Gr-1 at 4 weeks. (L) Total OARSI score in different groups after injection of anti-Gr-1. (T: tibial, F: femoral) (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001). (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)
Article Snippet: After rinsing the cells three times with PBS, collagen II alpha-1 chain (COL2A1) and matrix metalloproteinase 13 (MMP-13) antibodies (Boster, China) diluted at 1:100 were added and incubated overnight at 4 °C in a constant temperature shaker.
Techniques: Injection, Control, Flow Cytometry, Expressing, Immunofluorescence, Staining, Membrane, Cell Culture, Micro-CT